Sudeep Pharma 2026 Report: Pharma Excipients and Battery Growth
Sudeep Pharma, listed on NSE in November 2025, reports 49% revenue growth to 172 crore in Q3 FY26 and enters battery materials via iron phosphate for EVs.
Indian Stocks on NSE & BSE
Sharp analysis on Indian-listed equities — written for investors who want signal, not noise. Independent, daily, and free to read.
Browse by topic
More recent posts
Tata Technologies UP Defence Corridor Plans and Skill Hubs
Tata Technologies proposes Common Facility Centres in Jhansi and Chitrakoot under UP Defence Industrial Corridor with ₹35,526 crore investment proposals.
RBI Cancels Paytm Payments Bank Licence: Complete Story From Beginning To April 2026
RBI cancels Paytm Payments Bank licence effective April 24, 2026, ending a saga of KYC violations, compliance failures and restrictions since 2018.
Shipping Corporation of India Share Price Target 2026 to 2031: A Detailed Investment Outlook for SCI Stock
Shipping Corporation of India (SCI) trades at 290-295 rupees with a P/E of 12 and 2.3% dividend yield, backed by fleet expansion plans for 26 new vessels…
Bhagyanagar India Stock Surges to New Highs in April 2026: NCLT Admits Tieramet Demerger Petition – Full Details
Bhagyanagar India Limited (BHAGYANGR) shares have hit fresh all-time highs after the NCLT Hyderabad Bench admitted the long-awaited Composite Scheme of…